BEDFORD, Mass., Jul 09, 2015 (BUSINESS WIRE) — Anika Therapeutics, Inc., ANIK, +0.35% a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today reported positive results from the CINGAL® 13-02 study evaluating the safety of a repeat